Research highlight

Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury

Jiri Aubrecht , Shelli J Schomaker and David E Amacher

Genome Medicine 2013, 5:85 (27 September 2013)

New biomarkers to improve the diagnosis and treatment of drug-induced liver injury are being uncovered using genomic and proteomic approaches and are likely to provide better prediction of outcomes.

Subscription required

All research articles in Genome Medicine are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help